高血糖症とは、血糖値が異常に高くなった時に起こる症状です。原因として、食べ物や運動の選択、病気、非糖尿病治療薬、あるいは十分なグルコース低下薬を摂取していないことなどが挙げられます。症状には頻尿、視力障害、疲労性頭痛、吐き気・嘔吐、ドライマウス、昏睡、混乱状態などが挙げられます。治療法には抗高血糖治療およびインスリン治療があります。
目次
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hyperglycemia - Overview
Hyperglycemia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hyperglycemia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hyperglycemia - Companies Involved in Therapeutics Development
Auxulin Pharmaceuticals Inc
Boryung Pharmaceutical Co Ltd
FGH BioTech Inc
Guangzhou General Pharmaceutical Research Institute Co Ltd
Protheragen Inc
Hyperglycemia - Drug Profiles
AUX-101 - Drug Profile
Product Description
Mechanism Of Action
Drugs to Inhibit ABHD6 for Metabolic Disorders - Drug Profile
Product Description
Mechanism Of Action
FGH-10019 - Drug Profile
Product Description
Mechanism Of Action
GPCR-targeted Project 014 - Drug Profile
Product Description
Mechanism Of Action
KR-62980 - Drug Profile
Product Description
Mechanism Of Action
Small Molecule to Agonise PPARG and Antagonize AGTR1 for Hyperglycemia and Hypertension - Drug Profile
Product Description
Mechanism Of Action
Small Molecule to Inhibit SGLT2 for Hyperglycemia and Thrombosis - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Antagonize PST Receptor for Dysglycemic States - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Inhibit PEPCK for Hyperglycemia - Drug Profile
Product Description
Mechanism Of Action
Synthetic Peptides to Antagonize Glucagon Receptor for Hyperglycemia and Type 2 Diabetes - Drug Profile
Product Description
Mechanism Of Action
Hyperglycemia - Dormant Projects
Hyperglycemia - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Hyperglycemia, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Hyperglycemia - Pipeline by Auxulin Pharmaceuticals Inc, 2022
Hyperglycemia - Pipeline by Boryung Pharmaceutical Co Ltd, 2022
Hyperglycemia - Pipeline by FGH BioTech Inc, 2022
Hyperglycemia - Pipeline by Guangzhou General Pharmaceutical Research Institute Co Ltd, 2022
Hyperglycemia - Pipeline by Protheragen Inc, 2022
Hyperglycemia - Dormant Projects, 2022
Hyperglycemia - Discontinued Products, 2022
List of Figures
Number of Products under Development for Hyperglycemia, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
